Categories: BrainNews

Ibogaine By David Dardashti: Government Urged to Increase Funding for Quantum Electrodynamics Research

Exploring the Relationship Between Glial Cells and Electromagnetic Waves

David Dardashti and Quantum Electrodynamic

Ibogaine By David Dardashti supports quantum electrodynamics

MIAMI, March 15, 2024 (GLOBE NEWSWIRE) — Ibogaine By David Dardashti today announced that they are advocating to the government to increase funding allocated for research into the relationship between glial cells and electromagnetic waves.

Catalyzing Glial Cells

Ibogaine hydrochloride has been used to catalyze the production of glial cells in response to electromagnetic waves within the brain. “Maxwell’s unified field theory suggests that electric current and light particles have the potential to create a high level of interconnectivity, which can be used to measure photon emission. By studying electroencephalogram readings during ibogaine treatment, we can predict electromagnetic waves that may enhance utilization the photoelectric effect process. This could be used to maximize solar power efficiency and create economic and environmental benefits.” Ibogaine By David Dardashti plans to share this proposition with a major U.S. legal organization and is expecting a positive response. “We feel strongly that this research has the potential to open massive doors for a more sustainable future. It will be one of our great pursuits to make this vision a reality and to create a safe, healthy, and prosperous society,” said Dr. Dardashti.

Ibogaine hydrochloride has the potential to be used to measure photon emission in response to electromagnetic waves, offering new economic and environmental benefits and providing a more sustainable future.

Ibogaine By David Dardashti encourages the U.S. government to increase funding for research initiatives that explore the relationship between glial cells and electromagnetic waves.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/e13e14b0-f2f2-4b61-8094-dd33564c00e9

CONTACT: Gavriel Dardashti
+17869301880
gavriel@ibogaineclinic.com

Staff

Recent Posts

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

20 minutes ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

20 minutes ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

1 hour ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

3 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

3 hours ago

Hallmark Adds Senior Executives to Enhance Customer Success and Strategic Partnerships

New leadership roles highlight Hallmark’s unique vendor-neutral approach to helping health systems build flexible, efficient,…

3 hours ago